Expression of c-kit receptor (CD117) and CD34 in leukemic cells

Leukemia & Lymphoma
K MuroiY Miura

Abstract

The expression of c-kit receptor (c-kit R; CD117) and CD34 was examined in acute myeloid leukemia (AML), acute lymphoid leukemia (ALL), chronic myeloid leukemia (CML) in blastic transformation (BT), and myelofibrosis (MF) in myeloid BT. In myeloid leukemia including AML, CML-myeloid BT and MF-myeloid BT, both c-kit R and CD34 were expressed synchronously, while in lymphoid leukemia including ALL and CML-lymphoid BT, only CD34 was highly expressed. A close correlation between c-kit R and CD33 expression and an inverse correlation between c-kit R and CD19 expression were observed when all of the myeloid plus lymphoid leukemia cells were analysed. There was a close correlation between c-kit R and CD34 expression in the myeloid leukemia cells. c-kit R expression may be associated with myeloid phenotypes of leukemic cells and may be useful for the diagnosis of myeloid leukemia. The literature of c-kit R expression in leukemic cells is reviewed here and the comparison of c-kit R and CD34 expression in normal hematopoietic progenitor cells with those on the leukemic counterparts was discussed.

References

Apr 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·C M BaumB Peault
Jul 1, 1991·British Journal of Haematology·J M BennettC Sultan
Oct 1, 1990·British Journal of Haematology·F Brito-BabapulleG J Mufti
Dec 1, 1986·Mayo Clinic Proceedings·W D TravisP M Banks
Nov 1, 1993·British Journal of Haematology·K MuroiY Miura
Sep 1, 1993·The Journal of Experimental Medicine·M E MatosM A Caligiuri
Oct 1, 1993·The Journal of Experimental Medicine·Y MatsuzakiH Nakauchi
Apr 1, 1993·American Journal of Clinical Pathology·S T Traweek
Jan 1, 1994·Journal of Psychopharmacology·B D Scheepers, D G Rogers

❮ Previous
Next ❯

Citations

May 6, 1999·Leukemia Research·J F NomdedéuE Rubiol
Oct 3, 1999·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·A LegitimoP Macchia
Jun 7, 2008·Hematology·Ana VidovićDarinka Bosković
Aug 26, 1998·Leukemia & Lymphoma·L EscribanoJ F San Miguel
Sep 24, 1999·Leukemia & Lymphoma·L K AshmanA C Cambareri
Apr 1, 1997·Leukemia & Lymphoma·K W SykoraA Reiter
Mar 18, 2000·Leukemia & Lymphoma·L K AshmanA C Cambareri
Jan 14, 2017·Journal of Cellular Physiology·Hamed MirzaeiHamid Reza Mirzaei
Apr 12, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Abbas AhmadiAmir Amini
Jan 27, 1998·Hematology/oncology Clinics of North America·C M Verfaillie

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

CNS Lymphoma

In CNS lymphoma, cancerous cells from lymph tissues or other parts of the body form tumors in the brain and/or spinal cord. Here is the latest research on this rare non-Hodgkin lymphoma.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.